Dr. David Euhus, surgical oncologist at UT Southwestern Medical Center in Dallas, TX

David Euhus, M.D.

Professor
Surgery

Meet Dr. David Euhus
Breast Cancer Surgeon and Genetics Specialist

Holder of the:

  • Marilyn R. Corrigan Distinguished Chair in Breast Cancer Surgery
  • Mary L. Brown Breast Cancer Genetics and Risk Assessment Program

David Euhus, M.D., is an internationally recognized expert in breast cancer. He treats a wide range of patients, including those at high risk for cancer. He is committed to understanding why breast cancer occurs at its basic, molecular levels and the most effective options for fighting it.

When we understand the causes of this disease and its triggers, we can empower patients to fight cancer.”

In addition to his specialty in breast surgery oncology, Dr. Euhus is co-director of the Mary L. Brown Breast Cancer Genetics and Risk Assessment Clinic in the Center for Breast Care at UT Southwestern Medical Center. Since joining UT Southwestern more than 15 years ago, he developed the CancerGene software program. This groundbreaking tool is used in more than 4,000 cancer centers throughout the world and has helped transform the way doctors work with patients to identify their inherited risk for breast cancer. A fascinating development in the fight against breast cancer is the discovery of a growing number of genetic mutations linked to cancer – such as variations of the BRCA1, BRCA2, CDH1, PTEN, STK11, and TP53 genes. Dr. Euhus and UT Southwestern’s Cancer Genetics team can successfully help identify patients with mutations and work with them to develop the best pre-emptive strategies to fight cancer.

“It is extremely important for people with a family history of certain cancers to know their risks and understand what they can do to detect the disease as early as possible or take steps to protect their lives,” says Dr. Euhus.

Dr. Euhus is currently working with scientists at UT Southwestern to understand how excess body weight impacts the development and progression of breast cancer. The team is also developing new approaches for targeting fat to prevent and treat breast cancer. 

Clinical Interests

  • Breast cancer surgery
  • Nipple-preserving mastectomy
  • Cancer risk assessment
  • High-risk breast cancer patients
  • Cancer genetics
  • BRCA1, BRCA2, Lynch Syndrome, Cowden Syndrome and other genetic mutations
  • Lifestyle modification to prevent and manage breast cancer
  • Atypical Ductal Hyperplasia (ADH), Atypical Lobular Hyperplasia (ALH), Ductal Carcinoma in situ (DCIS),Lobular Carcinoma in situ (LCIS)